Using collaborative autoethnography to explore the teaching of qualitative research methods in medicine.

This article explores experiences of teaching qualitative research (QR) broadly, and qualitative methods (QM) more specifically in medicine, highlighting the challenges faced, and offering recommendations for overcoming them. Using collective online interviews, collaborative autoethnography (CAE) was employed to generate data comprising educator's reflective accounts of teaching QM in medical schools across two continents. Three main themes were identified through collaborative thematic analysis: making meaningful contributions from a marginalized position; finding our pedagogical feet; and recognizing the translational applicability and value of QR. We reflected on the marginalized positioning of QM in medical curricula and the underestimation of the value of QR to understanding pressing health issues. Analysis of these reflections pointed to a lack of formal training for educators and curriculum space for qualitative approaches. Our teaching pedagogies, developed through our own research experiences, self-reflection and student feedback, were primarily student-centered employing a range of novel approaches designed to foster skills and interest in the craft of QR, and introduce a greater appreciation of the significance of QR approaches to medicine. CAE further allowed us to identify some key recommendations that could help medical educators plan for teaching QM and other research methods more effectively in medicine. Future curriculum development should consider the benefits of exposing learners to a range of methods and approaches from across the qualitative-quantitative spectrum.

Cultural safety in hospitals: validating an empirical measurement tool to capture the Aboriginal patient experience.

Objective The aim of the present study was to develop a scale to measure cultural safety in hospitals from an Aboriginal patient perspective. Methods The Cultural Safety Survey was designed to measure five key characteristics of cultural safety that contribute to positive hospital experiences among Aboriginal hospital patients. Investigators developed a range of different methods to assess the validity and reliability of the scale using a sample of 316 participants who had attended a New South Wales hospital in the past 12 months. Targeted recruitment was conducted at two hospital sites. Opportunistic recruitment took place through a local health district, discharge follow-up service and online via social media. Results The Cultural Safety Survey Scale was a robust measurement tool that demonstrated a high level of content and construct validity. Conclusion The Cultural Safety Survey Scale could be a useful tool for measuring cultural safety in hospitals from the Aboriginal patient perspective. What is known about the topic? There are increasing calls by governments around the world for health institutions to enhance the cultural safety of their services as one way of removing access barriers and increasing health equity. However, currently there are no critical indicators or systematic methods of measuring cultural safety from the patient perspective. What does this paper add? The cultural safety scale, an Australian first, presents the first empirically validated tool that measures cultural safety from the Aboriginal patient perspective. What are the implications for practitioners? This measurement model will allow hospitals to measure the cultural safety of their services and ascertain whether current efforts aimed to improve cultural safety are resulting in Aboriginal patients reporting more culturally safe experiences. Over time it is hoped that the tool will be used to benchmark performance and eventually be adopted as a performance measure for hospitals across New South Wales.

Flutracking weekly online community survey of influenza-like illness: 2013 and 2014.

Flutracking is a national online community influenza-like illness (ILI) surveillance system that monitors weekly ILI activity and field vaccine effectiveness. This article reports on the 2013 and 2014 findings from Flutracking. From 2013 to 2014 there was a 14.0% increase in participants who completed at least 1 survey to 21,021 participants. By the end of the 2013 and 2014 seasons, respectively 59.7% and 59.1% of all participants had received the seasonal influenza vaccine. The 2013 Flutracking national ILI weekly incidence peaked in late August at 4.3% in the unvaccinated group, 1 week earlier than national counts of laboratory confirmed influenza. The 2014 Flutracking national ILI weekly incidence also peaked in late August at 4.7% in the unvaccinated group, in the same week as national counts of laboratory confirmed influenza. A lower percentage of Flutracking participants took two or more days off from work or normal duties in 2013 (peak level 1.6%) compared with 2014 (peak level 2.5%) and sought health advice in 2013 (peak level of 1.1%) compared with 2014 (peak of 1.6%). Flutracking ILI surveillance suggests that 2014 was a moderately more intense season than 2013 and similar to 2012.

Vaxtracker: Active on-line surveillance for adverse events following inactivated influenza vaccine in children.

Vaxtracker is a web based survey for active post marketing surveillance of Adverse Events Following Immunisation. It is designed to efficiently monitor vaccine safety of new vaccines by early signal detection of serious adverse events. The Vaxtracker system automates contact with the parents or carers of immunised children by email and/or sms message to their smart phone. A hyperlink on the email and text messages links to a web based survey exploring adverse events following the immunisation. The Vaxtracker concept was developed during 2011 (n=21), and piloted during the 2012 (n=200) and 2013 (n=477) influenza seasons for children receiving inactivated influenza vaccine (IIV) in the Hunter New England Local Health District, New South Wales, Australia. Survey results were reviewed by surveillance staff to detect any safety signals and compare adverse event frequencies among the different influenza vaccines administered. In 2012, 57% (n=113) of the 200 participants responded to the online survey and 61% (290/477) in 2013. Vaxtracker appears to be an effective method for actively monitoring adverse events following influenza vaccination in children.

Building influenza surveillance pyramids in near real time, Australia.

A timely measure of circulating influenza virus severity has been elusive. Flutracking, the Australian online influenza-like illness surveillance system, was used to construct a surveillance pyramid in near real time for 2011/2012 participants and demonstrated a striking difference between years. Such pyramids will facilitate rapid estimation of attack rates and disease severity.

Flutracking weekly online community survey of influenza-like illness annual report 2011 and 2012.

Flutracking is a national online community influenza-like illness (ILI) surveillance system that monitors weekly ILI activity and field vaccine effectiveness (FVE). This article reports on the 2011 and 2012 findings from Flutracking. There was a 22% increase in participants to 16,046 who completed at least one survey in 2012, compared with 2011 (13,101). By October 2012 (the end of the 2012 season), 54.2% of participants had received the 2012 seasonal vaccine, while by the end of the 2011 season, 55.9% of participants had received the 2011 seasonal vaccine. From 2007 to 2012 the FVE calculation for New South Wales participants demonstrated that the seasonal vaccine was effective except in 2009 when a novel H1N1 virus was dominant. The 2012 Flutracking ILI weekly incidence peaked in mid-July at 4.9% in the unvaccinated group, 1 month earlier than laboratory confirmed influenza. The 2011 Flutracking ILI weekly incidence peaked in mid-August at 4.1% in the unvaccinated group, 1 week later than laboratory confirmed influenza. Similar to laboratory notifications, there was an increase in ILI activity from 2010 to 2012, with the peak weekly ILI prevalence for 2012 Flutracking data, (unstratified by vaccination status), being higher (4.7%) than the peak weekly prevalence for 2011 (3.8%) and 2010 (3.7%). The 2012 Flutracking influenza season showed moderate levels of ILI, compared with lower levels of ILI seen in 2011 and 2010, and consistent with the increase in national influenza laboratory notifications.

Flutracking weekly online community survey of influenza-like illness annual report, 2010.

Flutracking is a national weekly online survey of influenza-like illness (ILI) completed by community members. Flutracking integrates participants' ILI symptom information with their influenza vaccination status to monitor influenza activity and field vaccine effectiveness (FVE). This report summarises results from the 2010 Flutracking season compared with previous seasons. Nationally, participation in Flutracking has more than doubled between 2008 and 2010, with 5,346 new participants enrolled or recruited in 2010 and a peak weekly participation of 10,773. By the end of the 2010 season, 5,904 of 9,109 (64.8%) participants had received the monovalent pandemic vaccine and/or the 2010 seasonal vaccine. From 2007 to 2010 FVE calculations demonstrated that the seasonal vaccine was effective except in 2009 during the pandemic. Peak 2010 ILI activity occurred in early June and August, and peak weekly 2010 ILI rates (4.2% among unvaccinated participants) were lower than the peak ILI rates during the 2009 pandemic (6.0% among unvaccinated participants). However, the decrease in laboratory notifications was much larger than the decrease in Flutracking rates. In summary, the number of Flutracking participants continued to steadily increase over the 2010 influenza season. The system has shown value in providing weekly vaccination uptake data during and beyond the 2009 influenza pandemic, as well as rapid FVE estimates that are qualitatively aligned with findings from other analyses of vaccine efficacy. Flutracking has also provided estimates of weekly community ILI activity that were not biased by health seeking behaviour and clinician testing practices.